Results 61 to 70 of about 1,698,554 (189)
AI is transforming TPD by improving the design, prediction, and optimization of degraders such as PROTACs, molecular glues, and LYTACs. This review summarizes key AI‐driven advances, highlights applications across drug discovery stages, and discusses remaining challenges and future directions for accelerating the development of therapies against ...
Shuanglin Qin +10 more
wiley +1 more source
Alzheimer's disease (AD) is considered the main cause of cognitive decline in adults. The available therapies for AD treatment seek to maintain the activity of cholinergic system through the inhibition of the enzyme acetylcholinesterase.
Humberto F. Freitas +2 more
doaj +1 more source
Assessment of machine learning reliability methods for quantifying the applicability domain of QSAR regression models [PDF]
The vastness of chemical space and the relatively small coverage by experimental data recording molecular properties require us to identify subspaces, or domains, for which we can confidently apply QSAR models.
Polajnar, Matija +18 more
core +1 more source
Molecular structure provides a complementary perspective on drug‐induced liver injury. Integrating 801 drugs across five DILI endpoints, our interpretable AI framework reveals endpoint‐dependent structural contributions and links predictive classification with molecular‐level interpretation, highlighting the complex interplay between clinical ...
Priya Kumari, Kunal Roy, Madhulika Gupta
wiley +1 more source
Structure-activity relationship revealed by 3D-QSAR and docking studies.
Structure-activity relationship revealed by 3D-QSAR and docking studies.
Gaokeng Xiao (550476) +7 more
core +1 more source
ABSTRACT Topical and transdermal pharmaceutical formulations are a large and diverse class of products, yet their optimisation remains a complex, resource‐intensive challenge. Statistical design‐of‐experiments approaches have long provided the methodological backbone for this process and have shown broad effectiveness across topical and transdermal ...
Yongrui Xiao +5 more
wiley +1 more source
In our present study we have developed a ligand based 3D QSAR of 27 flavonoids and congeners active against human lung cancer cell line (A549) using the Phase module of Schrödinger suit.
Sudhan Debnath* +3 more
doaj
Context: In recent years phosphodiesterase V acts as an attractive target for cardiovascular drug design and QSAR techniques are helpful for the optimization of structural requirements for designing novel compounds.
Prafulla Choudhari, Manish Bhatia
doaj +1 more source
ABSTRACT Long‐term exposure to low‐dose food contact materials (FCMs) has raised concerns regarding developmental toxicity. In the present study, we prioritized FCMs with potential developmental toxicity using a weight‐of‐evidence computational model, which predicted 127 chemicals to be of high concern.
Chia‐Chi Ho +7 more
wiley +1 more source
Drug Design and Discovery: The Long Road From Hansch Analysis to Artificial Intelligence
The evolution of quantitative structure–activity relationships (QSAR) is traced from the pioneering work of Hansch to its contemporary applications in drug discovery. Key developments in multidimensional QSAR, multivariate statistical analysis and machine learning, model validation, and multi‐objective optimization are discussed.
Anna Tsantili‐Kakoulidou
wiley +1 more source

